Nasopharyngitis (Common Cold) Market Share, Key Trends, Regional Outlook & Forecasts to 2016

Nasopharyngitis (Common Cold) Market Share, Trends, Growth, Size, Analysis and Overview, Pipeline Review, H1 2016

Global Markets Direct's, 'Nasopharyngitis (Common Cold) - Pipeline Review, H1 2016', provides an overview of the Nasopharyngitis (Common Cold) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Nasopharyngitis (Common Cold), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Nasopharyngitis (Common Cold) and features dormant and discontinued projects.

Browse Detail Report With TOC @ http://www.radiantinsights.com/research/nasopharyngitis-common-cold-pipeline-review-h1-2016

Scope

The report provides a snapshot of the global therapeutic landscape of Nasopharyngitis (Common Cold)
The report reviews pipeline therapeutics for Nasopharyngitis (Common Cold) by companies and universities/research institutes based on information derived from company and industry-specific sources
The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

Table Of Content

Table of Contents 2
List of Tables 4

Buy a Sample copy of This Report @ http://www.radiantinsights.com/checkout/158885

List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Nasopharyngitis (Common Cold) Overview 6
Therapeutics Development 7
Pipeline Products for...